If a client reports a persistent dry cough after starting an ACE inhibitor, what is the best nurse response?

When a client reports a persistent dry cough after starting an ACE inhibitor, the best response acknowledges that this symptom is a recognized side effect commonly associated with this class of medications. ACE inhibitors work by inhibiting the angiotensin-converting enzyme, which can lead to increased levels of bradykinin, a peptide that can cause a cough.

Understanding that this side effect is known and generally considered harmless helps to provide reassurance to the client, as it normalizes their experience while also emphasizing the importance of monitoring their symptoms. It is essential for patients to feel heard and informed about the effects of their medications, and recognizing the cough as a typical reaction can lead to a therapeutic relationship built on trust. However, if the cough becomes bothersome or persistent, further evaluation and potential adjustment of therapy might still be necessary.

This response also aims to discourage any immediate alarm about the cough indicating a more severe issue, while ensuring the client understands the importance of discussing their symptoms with their healthcare provider if they are concerned.